Search PubMed⌕ Search

Biomedical subjects

H D Ambos

Publications and source records attributed to H D Ambos.

At least 19 recordsLinked to original sources

Improved estimation of pericardial potentials from body-surface maps using individualized torso models.

Clinical applicability of inferred pericardial potentials is limited because accuracy is significantly affected by noise in surface electrocardiograms (ECGs), errors in electrode location on the torso model, and errors in the geometry and inhomogeneities of the torso model itself. To quantify effects of electrode location and geometric errors in torso-surface models, we measured locations of 190 electrodes used in body-surface mapping of 11 adults, along with over 2,000 sites on each torso surface. Measurements were made to within 2 mm with an Immersion Personal Digitizer. To quantify effects of errors in pericardial-surface models we also estimated heart position, size, and orientation in each subject from ultrasonic images registered to the body-surface coordinates. Known pericardial potentials were taken from epicardial measurements made during QRS with a 90-electrode sock in an adult male undergoing cardiac surgery. Body-surface ECGs were calculated for each individual from the pericardial maps, using standard boundary-element methods. Accuracy of zero-order-Tikhonov inverse solutions was tested in 91-node pericardial and 1,026-node torso models, individualized for each subject. With 10 microv rms noise added to surface potentials, the optimal regularization constant at each instant in QRS gave a relative error of 0.44 +/- 0.03; it was 0.47 +/- 0.03 using the composite residual and smoothing operator (CRESO) technique. When calculated body-surface potentials from the first 10 subjects were placed at corresponding electrode positions on the torso of the eleventh subject, whose heart size and orientation was the mean of the other 10 subjects, relative error increased to 0.87 +/- 0.06 for optimal regularization. CRESO failed in the fixed torso model. Results demonstrate that a fixed model does not provide useful estimates of pericardial potentials, and that individualized models enhance the performance of techniques for the estimation of regularization parameters.

Adult↗

Phase and group-delay characteristics of signal-averaged electrocardiograms from patients with ventricular tachycardia.

Fourier analysis of the signal-averaged ECG (SAECG) has previously revealed significant differences in magnitude spectra that differentiate patients with ventricular tachycardia (VT) from those without VT. To determine additional distinguishing features in the frequency domain, we analyzed phase spectra of SAECG's of sinus beats from 57 patients with VT, 65 without VT, and 20 normal controls. Unwrapped phase spectra from SAECG's of the entire cardiac cycle were calculated with respect to three fiducial points: onset of the P and Q waves, and the negative of the slope of the phase (group delay) for frequencies in the band, which accounted for 97.5% of the energy in the vector magnitude of the Frank SAECG leads. Phase spectra of SAECG's from patients with VT differed from the non-VT patients at frequencies > or = 21 Hz (p = 0.000039) for the P-wave fiducial, at frequencies > or = 60 Hz (p = 0.00085) for the Q-wave fiducial, and at frequencies < or = 62 Hz (p = 0.0035) for the 97.5% energy fiducial. Group delays in SAECG's from patients with and without VT differed from 10 to 26 Hz (p = 0.000016) for the P-wave fiducial, and from 14 to 24 Hz (p = 0.00000070) for the Q-wave fiducial. Group delays with respect to the Q-wave fiducial in the VT patients in the 14-24 Hz band were, on average, 9 ms and 5 ms longer than those of the non-VT's and normals, respectively. Thus, phase spectra of SAECG's contain previously undetected features that together with magnitude may be helpful in improving methods for stratifying the risk of VT.

Electrocardiography↗

Spectral analysis of the cardiac cycle of signal-averaged Frank leads from patients with ventricular tachycardia.

Identification of the spectral features in electrocardiograms that distinguish patients prone to ventricular tachycardia (VT) is a prerequisite to increasing the diagnostic power of the signal-averaged electrocardiogram (SAECG). To determine distinguishing features of the magnitude spectrum, the spectra of SAECGs of sinus beats were analyzed over the entire cardiac cycle from 32 patients with VT, 30 without VT, and 10 normal control subjects. The magnitude spectra of the Frank SAECGs separated patients with VT from those without VT over the band from 7 to 140 Hz with a P value of .000000047. To determine distinguishing features of phase and group-delay spectra, SAECGs of sinus beats over the entire cardiac cycle were analyzed from 57 patients with VT, 65 without VT, and 20 normal control subjects. Unwrapped phase spectra from SAECGs of the entire cardiac cycle were calculated with respect to the onset of the Q wave. Phase spectra of SAECGs from patients with VT differed from those from non-VT patients at frequencies of 60 Hz or greater (P = .00085). Average group delays in SAECGs from patients with and without VT differed (P = .00000069) from 14 to 24 Hz. Group delays in the VT patients in the 14-24-Hz band were on average 9 ms and 5 ms longer than those of the non-VTs and normal subjects, respectively. Time-domain reconstructions demonstrated that distinguishing frequency bands were detectable throughout the QRS complex, ST-segment, and T wave in SAECGs from each group. Thus, the spectra of SAECGs over the cardiac cycle contain features that together with temporal features from throughout the cardiac cycle are essential in improving methods for stratifying risk of VT.

Electrocardiography↗

Enhanced detection of distinguishing features in signal-averaged electrocardiograms from patients with ventricular tachycardia by combined spatial and spectral analyses of entire cardiac cycle.

BACKGROUND: Signals generated by myocardium responsible for ventricular tachycardia (VT) contribute to the entire QRS complex, ST segment, and T wave and are spatially distributed over the entire torso. However, current methods of signal-averaged ECG analysis restrict interrogation to the terminal QRS complex, do not include data on the body surface distributions of the distinguishing features detected, and have a limited clinical value because of a low positive predictive accuracy. Accordingly, we tested the hypothesis that frequency analysis of the entire cardiac cycle of spatially selected ECGs based on isoharmonic maps of the body surface enhance the detection of the unique spectral features in signal-averaged ECGs that differentiate patients with from those without VT. METHODS AND RESULTS: Isoharmonic maps of the body surface were calculated during sinus rhythm with the use of forward problem solutions for 32 patients with sustained VT, 30 without VT, and 10 healthy subjects and analyzed over a bandwidth of 0.05 to 470 Hz. Spectra of ECGs at the maximum and minimum of each patient's isoharmonic map of 1 to 7 Hz demonstrated a broadened bandwidth of significant separation (P < .05) for patients with from those without VT compared with the separation achieved with the use of Frank ECGs alone. Furthermore, the statistical significance within the bands of separation was greater for spatially selected ECGs compared with the Frank leads. Frank leads separated patients over the band from 11 to 84 Hz with a mean value of P = .0094. ECGs at the maximum of 1-to-7-Hz isoharmonic maps separated patients over the 8-to-111-Hz band with a mean value of P = .0062 (range, P < .05 to P < .0000001). ECGs at the minimum of 1-to-7-Hz isoharmonic maps extended the low-frequency end of the band of separation, which covered 0 to 69 Hz with a mean value of P = .0039 (range, P < .05 to P < .0000001). Subgroup analysis verified that results were independent of QRS duration. CONCLUSIONS: Spectral analysis of ECGs that are spatially selected for each patient is superior to orthogonal ECGs and augments detection of distinguishing features in ECGs that identify risk of VT. The new data acquired from analysis of spatially selected ECGs from individual patients provide the information on the specific frequency bands and an improved ECG-lead system required to refine methods of analysis of the signal-averaged ECG.

Aged↗

Radiation exposure to patients and medical personnel during radiofrequency catheter ablation for supraventricular tachycardia.

Radiofrequency catheter ablation is an effective alternative to medical therapy for patients with supraventricular arrhythmias. The purpose of this study was to determine the risks to the patient and to medical personnel due to radiation exposure from fluoroscopy during radiofrequency ablation of supraventricular tachycardia. One hundred eight consecutive patients with Wolff-Parkinson-White syndrome or atrioventricular nodal reentry who underwent the ablation procedure were studied. The ablation procedure was successful in 95% of the patients studied. Preexcitation or supraventricular tachycardia recurred in 5% of the patients during a mean follow-up of 9 +/- 4 months. The mean fluoroscopy time was 50 +/- 31 minutes. An anthropomorphic radiologic phantom was used to determine organ exposure and the effective dose equivalents for the patient and medical personnel. The patient's effective dose equivalent during a representative ablation procedure was 1.7 rems, which is comparable to other invasive cardiovascular procedures. The risk of inducing a fatal cancer from this exposure is 1 chance in 745, which is 1% of the spontaneous risk. The risk of a serious birth defect is 1 chance in 80,000, which is 0.1% of the current incidence of serious birth defects in the United States. The cardiologist who receives the highest exposure among medical personnel, would incur 1.8 mrems per case or 450 mrems per year if 250 procedures were performed. This exposure is 9% of the recommended annual limit. These results demonstrate the efficacy of radiofrequency energy ablation of supraventricular tachycardia and confirm that radiation exposure to patients and medical personnel is within established guidelines.

Electrocoagulation↗

Prospective detection of vulnerability to sustained ventricular tachycardia in patients awaiting cardiac transplantation.

This prospective study tested the hypothesis that abnormal signal-averaged electrocardiograms (ECGs) and inducible ventricular arrhythmias identify patients awaiting cardiac transplantation who are prone to sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). Thirty-seven patients with advanced symptoms of heart failure and a mean left ventricular ejection fraction of 20 +/- 7 were studied. In response to programmed ventricular stimulation using up to 3 extrastimuli, sustained monomorphic VT was induced in 8 (22%) and polymorphic VT or VF was induced in 5 patients (13%). Patients with inducible arrhythmias underwent drug therapy guided by results of programmed ventricular stimulation or implantation of a defibrillator. Patients in whom ventricular arrhythmias could not be induced were not treated for arrhythmias. The signal-averaged ECG was abnormal and sustained VT or VF was induced in 10 patients (27%). Follow-up ranged from 1 to 33 months (mean 12). Four patients (11%) died suddenly and 4 (11%) had nonfatal sustained VT or VF. The positive predictive value for sudden death or nonfatal VT/VF was 27% for the signal-averaged ECG, 38% for programmed ventricular stimulation, and 50% if both tests were abnormal. The negative predictive values for these tests were 87, 88 and 88%, respectively. The actuarial incidence of arrhythmic events was significantly higher in patients with inducible ventricular arrhythmias (p = 0.017) and in patients in whom both the results of signal-averaged electrocardiographic analysis and the response to programmed ventricular stimulation were abnormal (p = 0.002). This study demonstrates that results of signal-averaged electrocardiographic analysis and the response to programmed ventricular stimulation improve risk stratification for sudden cardiac death in patients awaiting cardiac transplantation.

Actuarial Analysis↗

Diagnostic implications of spectral and temporal analysis of the entire cardiac cycle in patients with ventricular tachycardia.

BACKGROUND: Available methods for analysis of signal-averaged electrocardiograms (ECGs) have a low-positive predictive accuracy for identifying patients at risk for ventricular arrhythmias. Identification of the spectral and temporal features in ECGs that distinguish patients prone to ventricular tachycardia (VT) is a prerequisite to implementing refinements in methods that increase the diagnostic power of the signal-averaged ECG. METHODS AND RESULTS: Fast Fourier transforms and time-domain reconstructions based on inverse fast Fourier transforms were computed over the entire cardiac cycle of signal-averaged ECGs of sinus beats from 40 patients with myocardial infarction and sustained VT, 41 with infarction without VT, and 20 normal controls. Ventricular depolarization and repolarization were analyzed by procedures that obviate limited resolution due to short data segments and window functions. Spectral magnitudes of ECGs from patients in each group were compared, and the phase data were used for time-domain reconstructions to determine the temporal distributions of distinguishing frequency bands during the cardiac cycle. Magnitudes of 1-7-Hz frequencies were increased (from p less than 0.05 to p less than 0.00001), and magnitudes of 13-56-Hz and 70-128-Hz frequencies were decreased (from p less than 0.05 to p less than 0.00001) in the spectra of ECGs from patients with VT compared with patients without VT. Time-domain reconstructions demonstrated that 1-7-Hz frequencies were detectable throughout the QRS complex, ST segment, and T wave in ECGs from each group. The 13-56-Hz and 70-128-Hz frequency bands not only contributed to the terminal QRS and ST segment but were also detectable throughout the QRS complex of ECGs from patients with VT. CONCLUSIONS: Results define new spectral and temporal features in signal-averaged ECGs from patients with VT that are excluded from analysis by available techniques that limit the bandwidth or restrict interrogation to portions of the cardiac cycle. These findings provide an objective basis for developing new indexes for signal-averaged ECG analysis.

Electrocardiography↗

Noninvasive detection of patients with ischemic and nonischemic heart disease prone to ventricular fibrillation.

Abnormalities in the fast Fourier transforms of signal-averaged electrocardiograms (ECGs) obtained during sinus rhythm appear to distinguish patients with ischemic heart disease and sustained monomorphic ventricular tachycardia from those without ventricular tachycardia. This study was performed to determine the power of frequency analysis to detect patients with a history of ventricular fibrillation, to determine the extent to which spectra of signal-averaged ECGs from patients with ischemic and nonischemic heart disease are comparable and to compare results of signal-averaged ECG analysis in patients with ventricular fibrillation with results of programmed ventricular stimulation. Signal-averaged ECGs were obtained during sinus rhythm from 60 patients with sustained ventricular tachycardia (Group I) and 34 patients with ventricular fibrillation (Group II). Results of signal-averaged ECG analysis were abnormal in 92% of patients with ventricular tachycardia and 85% of patients with ventricular fibrillation (p = NS). Abnormal spectra were detected in the signal-averaged ECGs from 90% of patients with ischemic and from 86% of patients with nonischemic heart disease (p = NS). In contrast, the results of programmed stimulation differed markedly between the two patient groups. Sustained ventricular arrhythmias were induced in 91% of the patients with ventricular tachycardia compared with only 46% of those with ventricular fibrillation (p less than 0.0001). Moreover, ventricular tachycardia was inducible in 81% of patients with ischemic heart disease compared with only 50% of those with nonischemic heart disease (p less than 0.02). Thus, abnormalities in the spectra of signal-averaged ECGs were found in the majority of patients with ventricular fibrillation and were detectable even in those whose arrhythmia was not inducible by programmed stimulation. These results broaden the potential clinical application of noninvasive interrogation of signal-averaged ECGs to include the prospective identification of patients with ischemic or nonischemic heart disease prone to ventricular tachycardia or ventricular fibrillation.

Cardiac Pacing, Artificial↗

Improved differentiation of patients with and without ventricular tachycardia by frequency analysis of multiple electrocardiographic leads.

Previously, these investigators have analyzed fast Fourier transforms of signal-averaged electrocardiograms (ECGs) to distinguish patients with from those without sustained ventricular tachycardia (VT). In these studies, analysis was performed on X, Y and Z ECG signals and patient to patient comparisons were based on an average of the X, Y and Z results. The purpose of this study was to determine the extent to which fast Fourier transform analysis of individual ECG leads and of the vector magnitude contribute to the differentiation of patient groups. Studies were performed in 28 normal subjects (group I), 38 patients with prior myocardial infarction but without VT (group II), 38 patients with anterior infarction and sustained VT (group III) and 29 patients with inferior infarction and sustained VT (group IV). Results in group I were used to define normal values for the area and peak magnitude ratios for the individual X, Y and Z leads and for the vector magnitude and to define normal values for the mean XYZ area and peak magnitude ratios. Spectra of the X, Y and Z leads, the vector magnitude and the mean XYZ results were significantly different in patients with VT compared with normal subjects and patients without VT (p less than 0.001). Results were abnormal in multiple leads from 71% of patients with VT and from only 5% of normal subjects (p less than 0.0001). In many patients with VT, abnormalities were identified in 2 of the 3 leads indicating a selective spatial distribution of altered ECG signals that elicit abnormal frequency components.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗

Identification of patients with sustained ventricular tachycardia by frequency analysis of signal-averaged electrocardiograms despite the presence of bundle branch block.

Previously, we have demonstrated distinguishing features in the fast Fourier transform (FFT) of signal-averaged electrocardiograms (ECGs) obtained during sinus rhythm in the absence of bundle branch block that differentiate patients with from those without sustained ventricular tachycardia (VT). The ECGs during sinus rhythm from many patients with sustained VT, however, exhibit intraventricular conduction abnormalities. Accordingly, this study was performed to determine whether the presence of bundle branch block during sinus rhythm precluded accurate identification of patients with sustained VT. Studies were performed in 28 normal subjects (group I) and 141 patients with organic heart disease grouped according to clinical characteristics. Group II comprised 40 patients without VT in whom the QRS duration during sinus rhythm was less than 120 msec. Group III included 21 patients without VT in whom the QRS duration during sinus rhythm was 120 msec or greater. Group IV comprised 43 patients with sustained VT having ECGs during sinus rhythm with QRS durations less than 120 msec. Group V included 37 patients with sustained VT in whom the QRS duration during sinus rhythm was 120 msec or greater. FFTs of the terminal QRS and ST segment of signal-averaged X, Y, and Z ECGs were computed. Transformed data were expressed as an FFT magnitude and the relative contribution and peak magnitudes of 20 to 50 Hz frequencies determined after first demonstrating that this FFT method was more appropriate, when compared with the energy spectrum, for analyzing ECG signals having a broad range of ST segment durations.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗

Metabolism of beta-methyl[1-11C]heptadecanoic acid in canine myocardium.

To assess the contributions of metabolism to CO2 and back-diffusion of nonmetabolized tracer to total clearance of beta-methyl[1-11C]heptadecanoic acid ([1-11C]BMHDA) from myocardium and its distribution into lipid pools, 10-15 mCi of [1-11C]BMHDA were rapidly infused into the circumflex coronary artery of seven open-chest dogs. Externally detected clearance of myocardial 11C-activity was protracted (t1/2 = 41 +/- 18 min) with over 50% of extracted tracer retained in tissue after 20 min. Efflux of extracted [1-11C]BMHDA between 5 and 20 min was comprised of both 11CO2 (16.5 +/- 15.2%) and nonmetabolized [11C]BMHDA (24.6 +/- 11.5%). At 20 min, 11C-activity in lipid was distributed primarily between triglyceride (47 +/- 16% of total) and phospholipid (39 +/- 17%) pools. Partial oxidation to 11CO2 and partitioning into more than one lipid pool are likely to hinder evaluation of fatty acid metabolism based on residue detection of [1-11C]BMHDA with tomography.

Animals↗

Improved selection of patients for programmed ventricular stimulation by frequency analysis of signal-averaged electrocardiograms.

Improved selection of patients with suspected sustained ventricular tachycardia (VT) for programmed ventricular stimulation is needed. To determine if frequency analysis detects patients in whom sustained VT might be induced, we first obtained fast-Fourier transforms (FFT) of signal-averaged electrocardiograms (ECGs) from 20 patients with spontaneous sustained VT (group 1) and compared them with the results of programmed ventricular stimulation with single and double extrastimuli during two cycle lengths and burst pacing from two right ventricular sites. The FFT data were expressed as an area ratio that quantified the relative contributions of 20 to 50 Hz frequencies in the terminal QRS and ST segment. A logistic regression with inducibility as the dependent variable was used to help define area ratio values greater than 20 as abnormal. Sustained monomorphic VT was induced in 18 patients, each with an area ratio value greater than 20. Sustained VT was not induced in two patients, each with an area ratio value less than 20. FFT data were then compared prospectively with the results of programmed stimulation in 38 patients (group II) with nonsustained VT (12 patients) or syncope (26 patients) referred for electrophysiologic study. In none of the 26 patients in group II with normal FFT values was VT inducible. Sustained monomorphic VT was induced in five of 12 patients with abnormal FFT values. Thus, the results of FFT analysis correctly predicted the results of programmed ventricular stimulation in 88% of patients studied and in 82% of patients in group II with syncope or nonsustained VT. Moreover, all five patients in group II in whom sustained VT was induced were identified correctly.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗

Quantification of differences in frequency content of signal-averaged electrocardiograms in patients with compared to those without sustained ventricular tachycardia.

To quantify differences in the frequency content of signal-averaged electrocardiograms between patients with and without sustained ventricular tachycardia (VT), the energy spectra of the terminal QRS and ST segments of signal-averaged orthogonal ECGs were computed in 3 groups of patients by squaring the magnitude of the fast-Fourier transformed data. The terminal 40 ms of the QRS complex and ST segment were analyzed as a single unit to enhance frequency resolution. Group I comprised 23 patients with documented, remote myocardial infarction who had manifested subsequent episodes of sustained VT; group II comprised 53 patients with previous, remote infarction without subsequent sustained VT; and group III comprised 11 normal subjects. The terminal QRS and ST segments from patients with sustained VT contained a 10- to 100-fold greater proportion of components in the 20- to 50-Hz range compared with corresponding electrocardiographic segments in patients without VT. There were no significant differences in the peak frequencies among patient groups. However, the relative contribution of the magnitudes of these peak frequencies to the overall maximum magnitude of the spectral plot differed significantly (p less than 0.0001). No frequencies above 50 Hz contributed substantially to the energy spectra of the terminal QRS and ST segments in any group. Thus, differences in the energy spectra do not result from differences in the frequencies of components, but are attributable instead to differences in the amplitudes of components within a relatively narrow range of frequencies. The quantitative approach developed should provide objective indexes for assessing effects of antiarrhythmic interventions on abnormalities recognizable by frequency-domain analysis and improve noninvasive definition of risk for development of sustained VT.

Adult↗

Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.

It has generally been assumed, from assessment of myocardial metabolism with [1(-11)C]palmitate and positron emission tomography, that clearance of the radiolabel from the myocardium is attributable solely to efflux of the products of oxidative metabolism. However, interpretations would differ if this assumption were unfulfilled. Furthermore, efflux of metabolized and nonmetabolized tracer has not been quantified. Accordingly, in this study, myocardium was perfused extracorporeally in 21 open-chest anesthetized dogs, and the extraction and clearance of [1(-11)C]palmitate were characterized under baseline conditions (normoxia, n = 21), and, again, with ischemia (n = 6), with hypoxia (n = 9), or under control conditions (n = 6). After intracoronary bolus injection of [1(-11)C]palmitate, myocardial time activity curves were measured with a beta-probe, and the products of oxidative metabolism (11CO2) and efflux of extracted but nonmetabolized fatty acid ("back-diffusion" of [1(-11)C]palmitate) were measured directly from analysis of arterial and regional coronary venous blood. Under control conditions, 45.2 +/- 3.8% (mean +/- SD) of initially extracted [1(-11)C]palmitate was metabolized to 11CO2, whereas 6.2 +/- 2.6% back-diffused in unaltered form in 1-10 minutes. In contrast, with ischemia (perfusion of 26% of baseline), only 16.9 +/- 9.8% of administered tracer evolved as 11CO2 (P less than 0.001 compared with control) but 15.6 +/- 8.9% (i.e., almost half of the total amount cleared) evolved unaltered as [1(-11)C]palmitate (P less than 0.05). Similarly, with hypoxia, 15.1 +/- 8.4% evolved as 11CO2 (P less than 0.0001) and 18.8 +/- 11.7% back-diffused (P less than 0.001). Overall, from 1-40 minutes after intracoronary injection of tracer, back-diffusion of [1(-11)C]palmitate contributed 40.6% of total radioactivity in the effluent with ischemia, 48.7% with hypoxia, but only 8.9% under control conditions. Despite the increased back-diffusion of [1(-11)C]palmitate seen with ischemia and hypoxia, the overall residue of 11C activity in myocardium increased, consistent with the diminished clearance observed in the myocardial time-activity curves and the increase in the tissue content of triglyceride and nonesterified fatty acid. Our results indicate that estimates of oxidative metabolism based upon clearance of radiolabeled fatty acid must take into account the efflux of initially extracted but nonmetabolized fatty acid. The findings apply to external determination of oxidative metabolism of the heart with any imaging modality that delineates retention and clearance of labeled fatty acids or their analogs.

Animals↗

Fast-Fourier transform analysis of signal-averaged electrocardiograms for identification of patients prone to sustained ventricular tachycardia.

Electrocardiograms obtained from patients during arrhythmia-free intervals do not identify those prone to sustained ventricular tachycardia (VT) despite the occult delayed activation that is presumably present. To determine whether frequency-domain analysis facilitates detection of this hallmark of predisposition to VT, fast-Fourier transform analysis (FFTA) procedures were developed and tested with a computer-generated mathematical model. The FFTA approach developed allows inherent limitations of high-gain amplification and a priori filtering used commonly for time-domain analysis to be avoided. After demonstrating that FFTA detected low-amplitude oscillatory waveforms in signal-averaged recordings in the frequency domain, the procedure was applied to signal-averaged X, Y, and Z lead recordings from the following three groups of patients: group I, patients with prior myocardial infarction and episodic sustained VT (n = 16); group II, patients with prior myocardial infarction without overt sustained VT (n = 35); and group III, normal control subjects (n = 10). Results of FFTA demonstrated significant (p less than .0001) differences in the decibel drop at 40 Hz and the area under the curve from the fundamental frequency to the frequency at which the spectral amplitude was decreased by 60 dB for both the terminal 40 msec of the QRS and ST segment in patients in group I compared with those in groups II and III, in whom results were similar. Results were independent of QRS duration (r = .2), left ventricular ejection fraction (r = .19), and complexity of spontaneous ventricular ectopy. Thus, patients known to manifest sustained VT also exhibited relatively greater high-frequency content in arrhythmia-free intervals in the terminal QRS and ST segment than those without VT (88%, 15%, and 0% in groups I through III, respectively). FFTA offers promise for the noninvasive detection of patients at risk for the development of sustained VT.

Aged↗

Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available.

Estimates of myocardial infarct (MI) size based on plasma creatine kinase (CK) are used widely for prognosis and in the assessment of therapy designed to salvage ischemic myocardium. However, if the initial plasma CK activity is elevated, MI size will be underestimated. To determine the impact of loss of early CK values on estimates of MI size and to develop a procedure to compensate for it, estimates of MI size based on complete and incomplete MB and total CK time-activity curves from 120 patients (experimental group) were compared. Estimates of MI size based on data inclusion intervals beginning at 24, 12, 8, and 4 hours before peak CK were 11, 14, 23, and 47% smaller than values based on complete CK curves, but the correlation was good between complete and incomplete estimates of MI size at any given interval, with r values ranging from 0.91 to 0.98. The derived correction factors were then prospectively applied to a new population (n = 25) with complete CK curves to compensate for purposely omitted early CK values. The corrected estimates of MI size were within 7% of those based on the complete CK curves. Similar results were obtained for transmural and nontransmural and anterior or inferior MI. Thus, if peak plasma CK is known, underestimation of MI size can be compensated for despite the unavailability of early CK values. Since greater than 90% of patients present before plasma CK has reached its peak (24 hours), MI size can be obtained in nearly all patients. Thus, being able to correct for unavailable early CK values makes MI size a more widely applicable endpoint for use in clinical trials and patient management.

Aged↗

Estimation of infarct size with MB rather than total CK.

We estimated infarct size in 95 patients with clinically uncomplicated infarction from total CK and results were compared to infarct size index based on plasma MB CK. Among patients with relatively low infarct size index indicative of relatively small infarctions (less than or equal to 20), estimates with total CK correlated closely with those based on MB CK (r = 0.88). In contrast, among patients with larger infarcts (infarct size index greater than 20) the correlation was poor. In this group, values for infarct size index based on total CK were 67 +/- 4 (SE)% greater than those based on MB CK. In the overall population, infarct size index based on MB (14 +/- 1 (SE) CK-gram-equivalents/m2) was less than that based on total CK (21 +/- 2). These disparities appear to reflect occult release of non-cardiac CK in patients with more extensive infarction. Thus, even in patients without overt clinical complications enzymatic estimates of infarct size are more accurate when based on MB rather than total plasma CK.

Adult↗